Abstract
We read with high interest the article by Clark et al.,1 in which the authors concluded that mobilizing a diverse group of stakeholders and focusing on policy and system changes generated significant reductions in health care use for asthma in vulnerable communities. In 2011 asthma was the second cause of hospitalizations for children and the third cause for adults in the Brazilian public health system.2 For this reason, since May 2012, the Brazilian government provided the medication beclomethasone for the treatment of patients with asthma.2 However, supplying this medication without correctly training the medical staff to diagnose asthma and administer the medication has rendered the decision less effective.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
